Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol

Introduction Standard treatment for nodular/bronchiectatic Mycobacterium avium complex lung disease (NB MAC-LD), excluding severe-status cases, differs between Japan and other countries. Internationally, three-drug combination intermittent treatment (three times a week administration) with macrolide...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Akiko M Saito, Yoshikazu Inoue, Taku Nakagawa, Hiroya Hashimoto, Mitsuaki Yagi, Yoshihito Kogure, Masahiro Sekimizu, Kenji Ogawa
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2019-10-01
coleção:	BMJ Open Respiratory Research
Acesso em linha:	https://bmjopenrespres.bmj.com/content/6/1/e000434.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!